Abstract:Most lung cancer patients cannot be cured with current therapeutic modalities. Drug resistance is one of the major causes in treatment failure of non-small cell lung cancer {NSCLC). Classical drug resistant mechanisms have been elucidated upon monocellular models. However, these models do not consider the tumor microenvironment in vivo. Recently, interactions between the tumor cells and extracellular matrix (ECM) have been shown to be one of the mechanisms of drug resistance. We investigated effects of ECM on cisplatin-induced apoptosis of the cell line A549 and cisplatin-resistant cell line A549-DDP, and the role of phosphatidylinositol 3'-kinase(PI3-K) in ECM's signal pathway. A549 and A549-DDP cells were cultured in RPMI 1640 supplemented with 10% fetal calf serum in vitro, 6 μmol/L cisplatin (DDP)was added to maintain the drug resistant phenotype of the A549-DDPcells. The inhibitory effects of DDP and/or LY294002 (PI3-K inhibitor) on cellular proliferation were tested by methabenzthiazuron (MTT) assay. Immunocytochemistry was used to detect the expression of extracellular matrix and integrin β1 of these two cell lines, respectively. Cell adhesion experiments were used to test cell adhesion rates. Flow cytometry was applied to study the influence of collegen IV (C IV) and LY294002 on A549/DDP cells' apoptosis and cell cycle distribution before and after DDP treatment. The expression of ECM proteins in cisplatin-sensitive and cisplatin-resistance lung cancer cells were different. Extracellular matrix Cmediated cell adhesion promotes survival of A549 and A549-DDP cells from cisplatin insults. Pre-coating with collagen IV protect non-small cell lung cancer cells from drug-induced growth inhibition, which is PI 3-kinase/Akt-dependent. Combining cisplatin with LY294002 caused greater increases in apoptosis compared with that caused by the inhibitor or cisplatin alone. Collagen IV changed A549 cells cell cycle distribution, with an increase in G1 phase, a reduction in S and G2/M phases, as treated with cisplatin or combined with LY294002. After being infected with dominant-negative forms of integrin β1 plasmid, both of these two cell lines can become relatively sensitive to cisplatin. ECM may provide protection against cisplatin-induced apoptosis of A549 and A549-DDP cells, while LY294002 increases the growth inhibitory effect of cisplatin. Integrin &β1 signaling and PI3-Kinase pathway may be important survival pathways of drug-induced apoptosis in lung cancer cells and activation of this pathway may contribute to the generation of drug resistance.

Role of Pannexin1 channels in the resistance of I-10 testicular cancer cells to cisplatin mediated by ATP/IP 3 pathway.

Targeting XPO6 Inhibits Prostate Cancer Progression and Enhances the Suppressive Efficacy of Docetaxel

CIP2A depletion potentiates the chemosensitivity of cisplatin by inducing increased apoptosis in bladder cancer cells.

P2-156: Effects of collagen IV on cisplatin-induced apoptosis of non-small cell lung cancer cells

Xanthatin Induce DDP-resistance Lung Cancer Cells Apoptosis Through Regulation of GLUT1 Mediated ROS Accumulation.

TNFα modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer

In Vitro Inhibited Effect of Gap Junction Composed of Cx43 in the Invasion and Metastasis of Testicular Cancer Resistanced to Cisplatin

GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin

PTPRZ1 Inhibits the Cisplatin Resistance of Ovarian Cancer by Regulating PI3K/AKT/mTOR Signal Pathway

TRPA1 promotes cisplatin-induced nephrotoxicity through inflammation mediated by the MAPK/NF-κB signaling pathway

PNA-TPP Targeting Drp1 of Lung Adenocarcinoma Cancer Stem Cells Enhance the Sensitivity to Cisplatin

Transcription Factor PRRX1-activated ANXA6 Facilitates EGFR-PKCα Complex Formation and Enhances Cisplatin Sensitivity in Bladder Cancer

Effect of Tumor Suppressor Gene PTEN on the Resistance to Cisplatin in Human Ovarian Cancer Cell Lines and Related Mechanisms.

Effects of aquaporins on chemosensitivity to cisplatin in ovarian cancer cells

A metastasis-associated Pannexin1 mutant (Panx1 ) forms a minimalist ATP release channel

Molecular Mechanism of Apoptosis in Cisplatin-Resistant Human Ovarian Cancer Cell Lines Promoted by Topotecan

The Role of Copper Transporter ATP7A in Platinum-Resistance of Esophageal Squamous Cell Cancer (ESCC).

Protein Tyrosine Phosphatase Receptor Type Z1 Inhibits the Cisplatin Resistance of Ovarian Cancer by Regulating PI3K/AKT/mTOR Signal Pathway.

Polyphyllin II (PPII) Enhances the Sensitivity of Multidrug-resistant A549/DDP Cells to Cisplatin by Modulating Mitochondrial Energy Metabolism.

[Effect of XPA Expression on the Chemotherapy Sensitivity of A549/DDP Cells].

Cisplatin-induced Non-Apoptotic Death of Pancreatic Cancer Cells Requires Mitochondrial Cyclophilin-D-p53 Signaling.